Search
|
Proceedings
|
Concurrent Oral Session Grid
|
Author Index
|
eBook
Author Index: C
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Cameron, C. G.
47
TRENDS IN THE USE OF INDIRECT COMPARISONS AND NETWORK META-ANALYSIS – EXPERIENCE FROM DRUG SUBMISSIONS FOR REIMBURSEMENT IN CANADA
Campagna, E.
D-2
WHO IS GUIDING DECISIONS ABOUT WHETHER TO PERFORM PEDIATRIC GASTRIC FUNDOPLICATION?
Campbell, D.
29
* HEALTHY FOOD CHOICES: THE ROLE OF FRONT OF PACK NUTRITIONAL LABELLING FORMAT
Campbell, J. D.
56
COMPARATIVE EFFECTIVENESS RESEARCH TO AID DECISION MAKING: RELATING CLINICAL OUTCOMES AND QUALITY ADJUSTED LIFE YEARS
TR1-5
* MODELING MEDICATION ADHERENCE BEHAVIOR IN COST-EFFECTIVENESS ANALYSIS: THE JUPITER EXAMPLE
Canaris, G.
51
DOES PQRI MAKE A DIFFERENCE?
Cantor, S. B.
PRE-MEETING DINNER SYMPOSIUM
Cantrell, C. R.
49
IMPACT OF NONCOMPLIANCE WITH DIABETES CARE GUIDELINES ON EMERGENCY ROOM VISITS AND HOSPITALIZATIONS IN A CALIFORNIA MEDICAID TYPE 2 DIABETES MELLITUS POPULATION
Carcone, S. M.
7
INTEGRATING QUANTITATIVE PREFERENCE-RELATED EVIDENCE INTO HEALTH TECHNOLOGY ASSESSMENT: THE CASE OF VENTILATION FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Carducci, M.
25
ARE INDICATORS OF QUALITY CARE FOR COMORBID CONDITIONS ASSOCIATED WITH COSTS OF CARE FOR PROSTATE, BREAST, AND COLORECTAL CANCER SURVIVORS AND MATCHED CONTROLS?
Carlson, J. J.
3
THE INFLUENCE OF PATIENT/PROVIDER BEHAVIOR ON THE VALUE OF ERCC1 TESTING RESEARCH IN STAGE II NON-SMALL CELL LUNG CANCER
33
EVALUATING A PROPOSED SWOG TRIAL OF BREAST CANCER TUMOR MARKERS: A VALUE OF RESEARCH AND BIOBANK ANALYSIS
C-6
ACCOUNTING FOR UNCERTAINTY IN THE AFFECTED POPULATION USED IN VALUE OF INFORMATION ANALYSES: AN APPLICATION IN ADVANCED BILIARY TRACT CANCER
Carlson, K.
M-2
PERSONALIZED DECISION SUPPORT FOR BREAST CANCER PREVENTION
Caro, J. J.
BD2-1
TASK FORCE UPDATE
Caron, M.
18
DO PATIENT-REPORTED OUTCOMES CONTRIBUTE TO REGULATORY DECISIONS IN THE USA AND EUROPE? A SYSTEMATIC REVIEW OF GUIDANCE DOCUMENTS AND AUTHORIZATIONS OF MEDICINAL PRODUCTS FROM 2006 TO 2010
Carpenter, D. M.
43
* HOW DO PATIENTS RESOLVE CONFLICTING MEDICATION RELATED INFORMATION?
53
SOURCES OF CONFLICTING MEDICATION INFORMATION: ASSOCIATIONS WITH DEMOGRAPHIC FACTORS AND MEDICATION ADHERENCE
Carroll, K.
M-5
DO INFORMED CONSENT DOCUMENTS MAKE GOOD DECISION AIDS?
Carrothers, J. M.
51
DOES PQRI MAKE A DIFFERENCE?
Carter, C. T.
28
ASSESSMENT OF INFLIXIMAB UTILIZATION PATTERNS ACROSS DIFFERENT SITES OF CARE FOR COMMERCIAL HEALTH PLANS
45
PATIENT-REPORTED PSORIASIS DISEASE FLARING AND IMPACT OF FLARE FREQUENCY ON HUMANISTIC OUTCOMES
48
LANDSCAPE OF BIOLOGIC FORMULARY MANAGEMENT AND PATIENT ACCESS IN PSORIASIS
56
PSORIASIS AND PSORIATIC ARTHRITIS PATIENT PRODUCTIVITY BURDEN IN THE UNITED STATES
58
BIOLOGIC EXPERIENCE AND SYSTEMIC MEDICATION USE AMONG COMMERCIALLY INSURED PSORIASIS PATIENTS RECEIVING USTEKINUMAB
Castellon, P. C.
24
BUDGET IMPACT OF RAPID HIV TESTING AND COUNSELING IN STD CLINICS IN THE UNITED STATES: A THRESHOLD ANALYSIS
Catherwood, D.
4
HEARTBEATS, WHY DO I MISS WHAT YOU TRY TO SAY TO ME? FOETAL MONITORING AND DECISION MAKING AROUND THE USE OF CARDIOTOCOGRAPHS IN A DAY ASSESSMENT UNIT
5
HEARTBEATS, WHY DO I MISS WHAT YOU TRY TO SAY TO ME? PATTERN RECOGNITION AND DECISION PROCESSES IN FOETAL MONITORING
Caughey, A. B.
9
* UNIVERSAL NEWBORN SCREENING FOR SEVERE COMBINED IMMUNODEFICIENCY: A COST EFFECTIVENESS ANALYSIS
11
ASSESSING WOMEN'S SOURCES OF CHILDBIRTH INFORMATION: ARE THEY ADEQUATELY INFORMED ABOUT INDUCTION OF LABOR AND CESAREAN DELIVERY?
16
* THE PRICE OF EMERGENCY CONTRACEPTION IN THE UNITED STATES: WHAT IS THE COST-EFFECTIVENESS OF ULIPRISTAL ACETATE VERSUS SINGLE DOSE LEVONORGESTREL?
21
* SHOULD CELL FREE FETAL DNA TESTING REPLACE ANTENATAL RHESUS IMMUNE GLOBULIN ADMINISTRATION?
34
ATTITUDES TOWARDS MODE OF DELIVERY CHOICE AMONG A DIVERSE POPULATION OF PREGNANT WOMEN
L-3
* A TRIAL OF LABOR AFTER CESAREAN DECISION ANALYSIS: THE IMPACT OF FUTURE PREGNANCIES
Chafen, J. S.
5
USAGE AND CHARACTERISTICS OF PATIENT SATISFACTION WEBSITES
29
REFERENCE PRICING: AN INNOVATIVE BENEFIT DESIGN FOR CONTROLLING MEDICAL EXPENDITURES
41
PRICE TRANSPARENCY: AN INNOVATIVE MEANS OF CONTROLLING MEDICAL EXPENDITURES?
Chambers, S.
32
* INVESTIGATING THE ROLE OF RISK PERCEPTIONS IN PREDICTING PROSTATE CANCER SCREENING BEHAVIOUR AS A FUNCTION OF FAMILY HISTORY: THE CONTRIBUTION OF AVAILABILITY AND REPRESENTATIVENESS HEURISTICS
40
* APPLYING VERBAL PROTOCOL ANALYSIS TO INVESTIGATE THE DECISION-MAKING STRATEGIES MEN USE WHEN CONSIDERING PROSTATE CANCER RISK FACTORS AND EARLY DETECTION SCREENING BEHAVIOUR: COMPARING MEN WITH AND WITHOUT A FAMILY HISTORY
A-4
* THE WEIGHT OF HISTORY: CAPTURING PROSTATE CANCER RISK AND SCREENING POLICIES FOR MEN WITH AND WITHOUT A FAMILY HISTORY USING A POLICY-CAPTURING APPROACH
Chang, C. H.
I-3
* APPLYING THE PAYOFF TIME FRAMEWORK TO CAROTID DISEASE MANAGEMENT
Chang, E.
B-5
A FRAMEWORK FOR MEASURING THE VALUE OF QUALITY IMPROVEMENT
Chang, S.
29
OBESITY AND MORTALITY IN PERSONS WITH AND WITHOUT OBESITY-RELATED DISEASES: USING DATA FROM NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY III
Chang, Y.
41
THE QUALITY OF DECISIONS ABOUT BREAST CANCER SURGERY
Charles, M.
TR2-3
* INTERNAL VALIDATION AND CALIBRATION OF A MODEL TO FORECAST HIV TREATMENT DEMAND AND CAPACITY IN HAITI
Chase, V.
L-4
* MODELING CARE UTILIZATION RATIOS TO GUIDE SURGE RESPONSES FOR NON-CRISIS EVENTS
Chauvin, F.
22
DECIDEO : INFORMED DECISION AND PARTICIPATION OF WOMEN TO THE NATIONAL SCREENING FOR BREAST CANCER : A QUALITATIVE OVERVIEW
Chen, Q.
22
ENHANCED SELF-EFFICACY REGARDING SKIN CANCER TREATMENT: THE IMPORTANCE OF INDIVIDUAL DIFFERENCE FACTORS VERSUS EXPOSURE TO A PATIENT DECISION AID
Chen, W.
K-3
COST-EFFECTIVENESS OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION TESTING FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER LIVING IN ONTARIO, CANADA
Cheng, Y.
21
* SHOULD CELL FREE FETAL DNA TESTING REPLACE ANTENATAL RHESUS IMMUNE GLOBULIN ADMINISTRATION?
L-3
* A TRIAL OF LABOR AFTER CESAREAN DECISION ANALYSIS: THE IMPACT OF FUTURE PREGNANCIES
Cherepanov, D.
B-5
A FRAMEWORK FOR MEASURING THE VALUE OF QUALITY IMPROVEMENT
Chermak, D.
L-2
* ESTIMATING THE COST OF NO-SHOWS AND EVALUATING THE EFFECTS OF MITIGATION STRATEGIES
Chhatwal, J.
C-4
TRANSFORMATION OF TRANSITION RATES AND PROBABILITIES IN DISCRETE-TIME MARKOV CHAINS: WHAT ABOUT COMPETING RISKS?
Chin, M. H.
J-6
FEASIBILITY OF A WEB-BASED TREATMENT DECISION TOOL FOR OLDER PATIENTS WITH DIABETES
Choi, H. K.
4
* DOES TREATMENT OF ASYMPTOMATIC HYPERURICEMIA IMPROVE HEALTH OUTCOMES? A DECISION- ANALYTIC EVALUATION
Choo, S. E.
32
A DECISION SUPPORT TOOL FOR CATEGORIZING PATIENT ACUITY AT EMERGENCY DEPARTMENT
Chren, M.
13
COMPARISON OF PREFERENCE ASSESSMENT METHODS BASED ON PROSTATE CANCER PATIENT CHARACTERISTICS
39
COMPREHENSIVE ASSESSMENT OF MEN'S PREFERENCES FOR PROSTATE CANCER CARE
Chu, L.
31
FACTORS ASSOCIATED WITH THE CHOICE OF BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS AMONG RHEUMATOID ARTHRITIS PATIENTS IN CALIFORNIA MEDICAID
Chubiz, J. C.
B-1
ADHERENCE WITH COLORECTAL CANCER SCREENING: DOES THE WAY YOU MODEL IT MATTER?
K-1
COST-EFFECTIVENESS OF ALTERNATING MRI AND DIGITAL MAMMOGRAPHY FOR SCREENING BRCA1 AND BRCA2 GENE MUTATION CARRIERS
Chung, J. W.
36
MINIMAL MODELING APPROACHES TO VALUE OF INFORMATION ANALYSIS
Chung, K. C.
6
* ULNAR NEUROPATHY AT THE ELBOW: A COST-UTILITY ANALYSIS
Cipriano, L. E.
22
* WITH MORE EFFECTIVE THERAPIES, SHOULD WE SCREEN FOR CHRONIC HEPATITIS C IN THE U.S.?
AM2
DETERMINISTIC DECISION ANALYTIC MODELS IN MICROSOFT EXCEL
E-4
* COST-EFFECTIVENESS OF RISK-FACTOR GUIDED AND UNIVERSAL SCREENING FOR CHRONIC HEPATITIS C INFECTION IN THE U.S
L-6
* TRANSCATHETER AORTIC VALVE IMPLANTATION SHOULD CHANGE THE MANAGEMENT OF NON-SURGICAL AORTIC STENOSIS CANDIDATES
PM8
PROBABILISTIC DECISION ANALYTIC MODELS IN MICROSOFT EXCEL
Clark, M.
38
MODELLING PATIENTS' PSYCHOLOGICAL CHARACTERISTICS, SELF-CARE BEHAVIOURS AND CLINICAL OUTCOMES TO INFORM A PATIENT-LEVEL SIMULATION MODEL OF DIABETES
Clarke, A.
8
HEALTH CARE COMMISSIONING IN THE ENGLISH NHS: EVIDENCE, CO-PRODUCTION AND QUALITY OF DECISIONS
23
RATIONAL DECISION MAKING REVISITED: INSIGHTS FROM STUDYING INDIVIDUAL HEALTHCARE FUNDING DECISIONS IN ENGLAND
Clay, K. F.
9
CAN HEALTH COACHING HELP PATIENTS WITH SPINAL STENOSIS MAKE AN INFORMED TREATMENT CHOICE?
Clayman, M. L.
A
DECISION PSYCHOLOGY LUSTED FINALISTS
Cleutjens, K. B.
8
* USE OF HIGH-SENSITIVE TROPONIN T ASSAY FOR THE EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION IN CHEST PAIN PATIENTS: AN ECONOMIC EVALUATION
Codella, J. V.
I-5
* USING AGENT-BASED SIMULATION TO EVALUATE POLICIES FOR CLOSTRIDIUM DIFFICILE INFECTION CONTROL IN A HOSPITAL
PM5
INTRODUCTION TO AGENT-BASED SIMULATION MODELING IN HEALTH CARE
Cohen, J. T.
O-4
POPULATION SCREENING TRADE OFFS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF SCREENING ASYMPTOMATIC CHILDREN FOR CARDIAC DISORDERS THAT CAUSE SUDDEN CARDIAC DEATH
Cohen, S. R.
10
ATTITUDES TOWARD PRENATAL TESTING AND PREGNANCY TERMINATION AMONG A DIVERSE POPULATION OF PARENTS OF CHILDREN WITH INTELLECTUAL DISABILITIES
Cohn, A.
L-4
* MODELING CARE UTILIZATION RATIOS TO GUIDE SURGE RESPONSES FOR NON-CRISIS EVENTS
Col, N. F.
AM6
MDM 101: COMMON MDM METHODS AND APPLICATIONS
J-6
FEASIBILITY OF A WEB-BASED TREATMENT DECISION TOOL FOR OLDER PATIENTS WITH DIABETES
Colditz, G. A.
29
OBESITY AND MORTALITY IN PERSONS WITH AND WITHOUT OBESITY-RELATED DISEASES: USING DATA FROM NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY III
Colfax, G. N.
24
BUDGET IMPACT OF RAPID HIV TESTING AND COUNSELING IN STD CLINICS IN THE UNITED STATES: A THRESHOLD ANALYSIS
O-2
DIFFERENCES BETWEEN MICRO-COSTING AND IMPLEMENTATION COSTS: EXAMPLE OF HIV RAPID TESTING AND COUNSELING IN A SUBSTANCE ABUSE TREATMENT PROGRAM
Cooke, D.
38
MODELLING PATIENTS' PSYCHOLOGICAL CHARACTERISTICS, SELF-CARE BEHAVIOURS AND CLINICAL OUTCOMES TO INFORM A PATIENT-LEVEL SIMULATION MODEL OF DIABETES
Cooney, E.
F-4
A RANDOMIZED TRIAL OF DEFAULT OPTIONS IN ADVANCE DIRECTIVES FOR PATIENTS WITH TERMINAL LUNG DISEASES
Cooper, G.
TR1-1
* THE USE OF PERSUASION IN PRIMARY CARE VISITS AND ITS EFFECT ON ADHERENCE TO PHYSICIAN-RECOMMENDED COLORECTAL CANCER SCREENING
Corbett, K.
50
THE IMPORTANCE OF INTERACTIONS IN DETERMINING HOW COMMUNITY PRACTITIONERS DIAGNOSE AND TREAT ACUTE RESPIRATORY TRACT INFECTIONS
Cordero-Coma, M.
2
* A COST-EFFECTIVENESS ANALYSIS OF OFF-LABEL BIOLOGICS TO TREAT SARCOID POSTERIOR UVEITIS VERSUS STANDARD OF CARE: COMPARING INFLIXIMAB TO METHOTREXATE AND SYSTEMIC STEROIDS
Corso, P.
16
SENSITIVITY OF THE EQ-5D FOR MEASURING MENTAL HEALTH IN AFRICAN-AMERICAN TEENAGERS
L
HEALTH ECONOMICS LUSTED FINALISTS.
Cosenza, C.
45
ASSESSING THE QUALITY OF BREAST CANCER SURGERY DECISIONS IN A NATIONAL MEDICARE SAMPLE
Coté, P.
31
COST-EFFECTIVENESS OF THE MOST COMMONLY USED NON-SURGICAL TREATMENTS FOR NECK PAIN
Cotte, F.
TR1-2
FACTORS INFLUENCING PHYSICIANS' THERAPEUTIC DECISION WHEN PRESCRIBING CHEMOTHERAPY: A DISCRETE CHOICE EXPERIMENT
Cox, V.
A-3
* EFFECTS OF DECISION AIDS ON DECISIONAL CONFLICT ASSOCIATED WITH OSTEOARTHRITIS TREATMENT
Coyne, K.
23
* CONSIDERATIONS FOR TARGETED RECRUITMENT OF PATIENTS WITH A CHRONIC CONDITION USING AN ONLINE SURVEY
Crape, B.
51
PERCEPTIONS AND REALITIES OF FOOD FORTIFICATION IN PREVENTING ANEMIA
Crespi, K.
G-2
COMPARATIVE PERFORMANCE OF CONJOINT ANALYSIS, TIME TRADE OFF, AND RATING SCALE METHODS OF PREFERENCE ASSESSMENT: PILOT DATA FROM A STUDY OF MEN AT RISK FOR PROSTATE CANCER
Crock, C. C.
3
DIAGNOSTIC ERROR AT THE EMERGENCY DEPARTMENT — MEDICAL IMAGING INTERFACE: AN AUSTRALASIAN SURVEY
Crowcroft, N.
59
AGENT-BASED APPROACH TO CONTACT PATTERNS MODELLING
Crump, R. T.
4
A GUIDING FRAMEWORK FOR THE EVALUATION OF VALUES CLARIFICATION EXERCISES
Curtis, L. A.
18
EVALUATION OF A DECISION AID FOR ANTIPSYCHOTIC MEDICATION
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
